logo

For the Inventor, By the Inventor

Le Mesnil Esnard, France

Gerard Charles Sanz

This inventor holds 19 USPTO granted patents, plus 2 CIPO patents. Top assignees: Janssen Pharmaceutica Nv, Hanssen Pharmaceutica, Janssen-Cilag S.a.. Active years: 1989-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gerard Charles Sanz. Retrieved from https://idiyas.com/inventor/gerard-charles-sanz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19

% Patents Active = 89.5


Average Co-Inventor Count = 3.9

ph-index = 9

Forward Citations = 321(Granted Patents)


Location History:

  • Garges les Gonesse, FR (1989 - 1997)
  • Le Mesnil Esnard, FR (1999 - 2008)

Company Filing History:

goldMedal17 out of 2,101 
 
Janssen Pharmaceutica Nv
 patents
silverMedal1 out of 1 
 
Hanssen Pharmaceutica
 patent
bronzeMedal1 out of 2 
 
Janssen-Cilag S.a.
 patents

Years Active: 1989-2008

Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents
1. 7378433 - N-[4-(heteroarylmethyl)phenyl]-heteroarylamines (2008-05-27),
2. 7205312 - N-[4-(heteroarylmethyl)phenyl]-heteroarylamines (2007-04-17),
3. 6833375 - N-[4-(heteroarylmethyl)phenyl]-heteroarylamines (2004-12-21),
4. 6486187 - N-[4-(heteroarylmethyl)phenyl]-heteroarylamines (2002-11-26),
5. 6444812 - Intermediate compounds in the preparation of farnnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N-or C linked imidazoles (2002-09-03),
6. 6187786 - Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles (2001-02-13),
7. 6169096 - Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives (2001-01-02),
8. 6124330 - N-[4-(Heteroarylmethyl)phenyl]-heteroarylamines (2000-09-26),
9. 6037350 - Farnesyl protein transferase inhibiting (2000-03-14),
10. 5968952 - Farnesyl transferase inhibiting 2-quinolone derivatives (1999-10-19),
11. 5922734 - 6-�triazolyl�3-(trifluoromethyl)phenyl!methyl!-2-quinolines and (1999-07-13),
12. 5612354 - (1H-azol-1-ylmethyl)substituted quinoline derivatives (1997-03-18),
13. 5441954 - (1h-azol-1-ylmethyl) substituted quinoline derivatives (1995-08-15),
14. 5268380 - (1H-azol-1-ylmethyl) substituted quinoline derivatives (1993-12-07),
15. 5185346 - (1H-azol-1-ylmethyl)substituted quinoline derivatives (1993-02-09),

Title: Innovations by Gerard Charles Sanz: A Focus on Pharmaceutical Patents

Introduction

Gerard Charles Sanz is an innovative inventor based in Le Mesnil Esnard, France. With a remarkable portfolio of 19 patents, he has made significant contributions to the field of pharmaceuticals, particularly through his work on novel compounds that have potential medical applications.

Latest Patents

Among his latest inventions is the patent titled "N-[4-(heteroarylmethyl)phenyl]-heteroarylamines." This innovation addresses compounds of a specific formula, which includes N-oxides, pharmaceutically acceptable addition salts, and stereochemical isomeric forms. These compounds have versatile functionalities where R can represent hydrogen, hydroxy, Calkyl, or aryl. The invention also delves into processes for the preparation of these new compounds and their formulations as potential medicines.

Career Highlights

Gerard has worked with esteemed companies in the pharmaceutical industry, including Janssen Pharmaceutica NV and Janssen-Cilag S.A. His experience in these organizations has undoubtedly contributed to his expertise and success as an inventor in the field of medicine.

Collaborations

Throughout his career, Gerard has collaborated with notable colleagues, including Marc Gaston Venet and Eddy J Freyne. Their joint efforts likely fostered an innovative environment, enhancing the research and development of groundbreaking pharmaceutical products.

Conclusion

Gerard Charles Sanz continues to be a vital contributor to the realm of pharmaceuticals through his innovative inventions and collaborative efforts. His work not only illustrates the importance of patents in protecting intellectual property but also emphasizes the impactful role of inventors in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…